CTXR

Citius Pharmaceuticals Inc.

Price

$0.60

return (12m)

-49.58%

p/e

-0.27

p/bv

0.21

DIVIDEND YIELD

0.00%

CTXR price

Citius Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CTXR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

3.81%

3 months

5.37%

1 year

-49.58%

2 years

-95.79%

5 years

-98.87%

10 years

-99.75%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals CTXR

Valuation

P/E

-0.27

Sector 1.09

Industry -1.78

P/BV

0.21

Sector 1.86

Industry 1.35

P/Revenue (PSR)

2.19

Sector 1.55

Industry 2.25

EV/EBITDA

-0.42

Sector -47.62

Industry -42.38

EV/EBIT

-0.42

Sector -27.52

Industry -45.58

P/EBITDA

-0.27

Sector -32.64

Industry -23.10

P/EBIT

-0.27

Sector -43.02

Industry -27.18

P/Total Assets

0.11

Sector 0.87

Industry 0.82

P/Net Current Assets

-0.68

Sector -27.09

Industry -72.46

P/Working Capital

-1.87

Sector -4.05

Industry -2.10

EPS

-2.22

Sector -0.70

Industry -1.11

BVPS

2.90

Sector 4.34

Industry 2.54

Efficiency

Gross Margin

77.34%

Sector 49.36%

Industry 50.48%

EBITDA Margin

-786.68%

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

-789.49%

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

-100.00%

Sector -19.73%

Industry -25.75%

Net Profit Margins

-100.00%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.01

Sector 0.13

Industry 0.06

Profitability

ROE

-76.63%

Sector -24.32%

Industry -33.33%

ROA

-40.89%

Sector -24.41%

Industry -45.72%

ROIC

-38.61%

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.84

Sector 1.90

Industry 2.51

Net Debt / EBITDA

0.90

Sector -4.96

Industry -8.98

Net Debt / EBIT

0.90

Sector -3.08

Industry -37.38

Net Debt / Equity

-0.14

Sector -0.45

Industry -1.16

Gross Debt / Equity

0.08

Sector -0.74

Industry -0.56

Equity/Assets

0.53

Sector 0.46

Industry 0.52

Liabilities/Assets

0.47

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

19.24%

Sector -

Industry -

Fundamentals CTXR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CTXR Citius Pharmaceuticals Inc.	$0.60	-49.58%	0.00%	-0.27	0.21	-76.63%	-100.00%
LLY Eli Lilly and Compay	$1,152.93	54.29%	0.59%	38.16	30.09	78.84%	33.53%
SNY Sanofi	$42.48	-7.32%	4.17%	3.97	0.73	18.43%	14.25%
GSK GlaxoSmithKline PLC	$50.22	29.16%	3.54%	15.39	4.35	28.24%	14.54%
CRMD CorMedix Inc.	$7.72	-31.07%	0.00%	3.22	1.31	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$23.62	-14.54%	0.00%	13.18	1.35	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.19	-17.43%	0.69%	27.59	2.49	9.03%	10.14%
ENLV Enlivex Therapeutics Ltd.	$0.81	-94.85%	0.00%	0.01	0.01	63.85%	0.00%
ISRG Intuitive Surgical Inc.	$393.33	-10.35%	0.00%	44.01	7.60	17.26%	28.62%
NVS Novartis AG	$140.37	16.41%	2.22%	20.89	6.35	30.39%	23.28%
TMO Thermo Fisher Scientific Inc.	$651.45	36.43%	0.28%	34.71	4.60	13.25%	15.07%
ABT Abbott Laboratories	$102.61	-22.85%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.13	0.84%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$43.34	-55.70%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$86.42	-29.33%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$224.99	-16.77%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$511.65	-22.02%	0.00%	35.48	25.07	70.67%	25.03%
HCA HCA Healthcare Inc.	$427.71	7.02%	0.70%	12.06	-29.52	-244.72%	10.07%
COHR Coherent Inc.	$317.36	190.86%	0.00%	75.62	5.36	7.09%	11.19%
DHR Danaher Corporation	$211.81	10.60%	0.68%	37.21	2.83	7.61%	15.95%
SYK Stryker Corp.	$275.12	-26.01%	1.26%	28.38	4.41	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CTXR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Citius Pharmaceuticals

Citius Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

19 years

Founded: 2007

2011

Time since IPO - 15 years

10

Employees

Citius Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $15.57 million, with shareholders equity totaling $75.91 million.

The company employs approximately 10 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Citius Pharmaceuticals Inc. reported $7.11 million in revenue, generating net income of $-58.17 million.

Key financial metrics include a P/E ratio of -0.27, a price-to-book (P/B) ratio of 0.21, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CTXR.

Market cap

$15.57 million

Net worth

$75.91 million

$75,908,000.00

Assets

$142.26 million

$142,255,000.00

Total Shares Outstanding

26.17 million

26,169,000

Average Daily Trading Volume

$626.54 Thousand

$626,544.00

Sector

Health

Industry

Pharmaceutical Products

CTXR

CTXR revenue and profits

Financial Results CTXR

DRAG THE FRAME TO SEE MORE DATA

CTXR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.84 22,33% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.28 --3,05% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.11 104,94% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$386.22 55,41% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.48 --7,32% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,152.93 54,29% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$427.71 7,02% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$140.37 16,41% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35